WallStreetZenWallStreetZen

NASDAQ: TOI
Oncology Institute Inc Earnings & Revenue

TOI past revenue growth

How has TOI's revenue growth performed historically?
Company
32.79%
Industry
8.54%
Market
17.86%
TOI's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TOI's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
TOI's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

TOI earnings and revenue history

Current Revenue
$309.9M
Current Earnings
-$75.4M
Current Profit Margin
-24.3%

TOI Return on Equity

Current Company
-79.8%
Current Industry
-81.9%
Current Market
-8.4%
TOI's Return on Equity (-79.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when TOI announces earnings.

TOI Return on Assets

Current Company
-31.9%
Current Industry
6.1%
TOI is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

TOI Return on Capital Employed

Current Company
-34.97%
Current Industry
13.1%
TOI's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TOI vs Medical Care Facility Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
TOI$309.88M-$59.54M-$75.41M+131.58%N/A
JYNT$117.70M$10.22M-$9.75M+26.27%N/A
CCEL$31.34M-$10.42M-$9.52M+1.41%N/A
CCM$84.23MN/A-$64.10M+19.42%N/A
ATIP$699.02M$79.15M-$131.97M-1.10%N/A

TOI earnings dates

Next earnings date
May 8, 2024

Oncology Institute Earnings & Revenue FAQ

What were TOI's earnings last quarter?

On Invalid Date, Oncology Institute (NASDAQ: TOI) reported Q3 2023 earnings per share (EPS) of -$0.19, up 533.33% year over year. Total Oncology Institute earnings for the quarter were -$17.42 million. In the same quarter last year, Oncology Institute's earnings per share (EPS) was -$0.03.

If you're new to stock investing, here's how to buy Oncology Institute stock.

What was TOI's earnings growth in the past year?

As of Q1 2024, Oncology Institute's earnings has grown year over year. Oncology Institute's earnings in the past year totalled -$75.41 million.

What is TOI's earnings date?

Oncology Institute's earnings date is Invalid Date. Add TOI to your watchlist to be reminded of TOI's next earnings announcement.

What was TOI's revenue last quarter?

On Invalid Date, Oncology Institute (NASDAQ: TOI) reported Q3 2023 revenue of $82.04 million up 26.25% year over year. In the same quarter last year, Oncology Institute's revenue was $64.98 million.

What was TOI's revenue growth in the past year?

As of Q1 2024, Oncology Institute's revenue has grown 32.79% year over year. This is 24.25 percentage points higher than the US Medical Care Facilities industry revenue growth rate of 8.54%. Oncology Institute's revenue in the past year totalled $309.88 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.